|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: ROYCE BIOMEDICAL INC, 10QSB, 2000-11-21 |
Next: EAGLE CAPITAL INTERNATIONAL LTD, 10-Q, 2000-11-21 |
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0000947011
<NAME> Royce Biomedical, Inc.
<MULTIPLIER> 1
<CURRENCY> US
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-2001
<PERIOD-START> JUL-1-2000
<PERIOD-END> SEP-30-2000
<EXCHANGE-RATE> 1
<CASH> 154,001
<SECURITIES> 0
<RECEIVABLES> 1,354
<ALLOWANCES> 0
<INVENTORY> 1,020
<CURRENT-ASSETS> 156,875
<PP&E> 0
<DEPRECIATION> 0
<TOTAL-ASSETS> 156,875
<CURRENT-LIABILITIES> 182,063
<BONDS> 0
0
0
<COMMON> 14,296
<OTHER-SE> (76,993)
<TOTAL-LIABILITY-AND-EQUITY> 156,875
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 36,704
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (36,704)
<INCOME-TAX> 0
<INCOME-CONTINUING> (36,704)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (36,704)
<EPS-BASIC> (0.01)
<EPS-DILUTED> (0.01)
</TABLE>
|
|